Surgery Websites
Willenbring Lab »  Publications

Publications

View by Year:
Rizvi AZ, Swain JR, Davies PS, Bailey AS, Decker AD, Willenbring H, Grompe M, Fleming WH, Wong MH
Bone marrow-derived cells fuse with normal and transformed intestinal stem cells.
Proceedings of the National Academy of Sciences of the United States of America, 2006-04-10.
Held PK, Al-Dhalimy M, Willenbring H, Akkari Y, Jiang S, Torimaru Y, Olson S, Fleming WH, Finegold M, Grompe M
In vivo genetic selection of renal proximal tubules.
Molecular therapy : the journal of the American Society of Gene Therapy, Jan-2006;13(1):49-58.  Epub 2005 Oct 10.
View Abstract | PubMed AbstractPlus 
Vogel A, Aslan JE, Willenbring H, Klein C, Finegold M, Mount H, Thomas G, Grompe M
Sustained phosphorylation of Bid is a marker for resistance to Fas-induced apoptosis during chronic liver diseases.
Gastroenterology, 2006-01-01.
Held PK, Al-Dhalimy M, Willenbring H, Akkari Y, Jiang S, Torimaru Y, Olson S, Fleming WH, Finegold M, Grompe M
In vivo genetic selection of renal proximal tubules.
Molecular therapy : the journal of the American Society of Gene Therapy, 2005-10-10.
Willenbring H
Therapeutic cell fusion.
The British journal of surgery, 2005-08-01.
Willenbring H, Grompe M
Delineating the hepatocyte's hematopoietic fusion partner.
Cell cycle (Georgetown, Tex.), 2004-12-15.
Willenbring H, Bailey AS, Foster M, Akkari Y, Dorrell C, Olson S, Finegold M, Fleming WH, Grompe M
Myelomonocytic cells are sufficient for therapeutic cell fusion in liver.
Nature medicine, 2004-06-13.
Willenbring H, Grompe M
Embryonic versus adult stem cell pluripotency: in liver only fusion matters.
Journal of assisted reproduction and genetics, 2003-10-01.
Wang X, Willenbring H, Akkari Y, Torimaru Y, Foster M, Al-Dhalimy M, Lagasse E, Finegold M, Olson S, Grompe M
Cell fusion is the principal source of bone-marrow-derived hepatocytes.
Nature, 2003-03-30.
Linnebank M, Tschiedel E, Häberle J, Linnebank A, Willenbring H, Kleijer WJ, Koch HG
Argininosuccinate lyase (ASL) deficiency: mutation analysis in 27 patients and a completed structure of the human ASL gene.
Human genetics, Oct-2002;111(4-5):350-9.
View Abstract | PubMed AbstractPlus 
Linnebank M, Tschiedel E, Häberle J, Linnebank A, Willenbring H, Kleijer WJ, Koch HG
Argininosuccinate lyase (ASL) deficiency: mutation analysis in 27 patients and a completed structure of the human ASL gene.
Human genetics, 2002-08-14.
Homberger A, Linnebank M, Winter C, Willenbring H, Marquardt T, Harms E, Koch HG
Genomic structure and transcript variants of the human methylenetetrahydrofolate reductase gene.
European journal of human genetics : EJHG, 2000-09-01.
Poremba C, Willenbring H, Hero B, Christiansen H, Schäfer KL, Brinkschmidt C, Jürgens H, Böcker W, Dockhorn-Dworniczak B
Telomerase activity distinguishes between neuroblastomas with good and poor prognosis.
Annals of oncology : official journal of the European Society for Medical Oncology, 1999-06-01.
Poremba C, Böcker W, Willenbring H, Schäfer KL, Otterbach F, Bürger H, Diallo R, Dockhorn-Dworniczak B
Telomerase activity in human proliferative breast lesions.
International journal of oncology, 1998-03-01.
Hiort O, Sinnecker GH, Willenbring H, Lehners A, Zöllner A, Struve D
Nonisotopic single strand conformation analysis of the 5 alpha-reductase type 2 gene for the diagnosis of 5 alpha-reductase deficiency.
The Journal of clinical endocrinology and metabolism, 1996-09-01.
Hiort O, Willenbring H, Albers N, Hecker W, Engert J, Dibbelt L, Sinnecker GH
Molecular genetic analysis and human chorionic gonadotropin stimulation tests in the diagnosis of prepubertal patients with partial 5 alpha-reductase deficiency.
European journal of pediatrics, 1996-06-01.
[    1  2  3   View All ]
X